How Long Can a Custom Peptide Be?
Quick answer
Chemical synthesis routinely delivers peptides of 10 to 40 residues, and experienced laboratories can reach 70 to 100 residues for favourable sequences. Beyond that, yield and purity fall sharply because incomplete coupling accumulates at every step. Long or difficult targets are usually handled by fragment condensation, native chemical ligation or recombinant expression rather than single-chain solid-phase synthesis.
Key facts at a glance
| Routine length | 10–40 residues by standard solid-phase synthesis |
|---|---|
| Stretch range | Up to roughly 70–100 residues for favourable sequences |
| Practical ceiling | About 120 residues, with lower yield and higher cost |
| Main limit | Cumulative incomplete coupling, not reactor size |
| Alternatives for long chains | Fragment condensation, native chemical ligation, recombinant expression |
| Hardest motifs | Hydrophobic stretches, multiple cysteines, poly-arginine, beta-sheet repeats |
The practical length limit for solid-phase synthesis
Solid-phase peptide synthesis builds a chain on a resin one residue at a time. Each coupling is a chemical reaction with a yield below 100%, typically in the high nineties for an easy residue but lower for a hindered or aggregating one. Because the steps multiply, overall yield falls exponentially with length even when each individual step looks excellent.
The arithmetic is unforgiving. At 99% average coupling efficiency, a 50-mer is produced in about 60% yield relative to the starting resin loading, while a 100-mer falls to roughly 37%. At 95% efficiency, those figures drop to about 8% and well under 1%. The truncated chains that remain are not inert; they are impurities that must be separated from a target that differs by only a few residues, which is chemically difficult.
This is why the honest answer to how long a peptide can be is a range with conditions attached. A well-behaved 60-mer is routine for a specialist laboratory; a 25-mer with four cysteines and a hydrophobic tail may be harder than either.
Which sequence motifs make synthesis difficult
| Motif | Why it is difficult | Common mitigation |
|---|---|---|
| Hydrophobic stretches | Chains aggregate on resin and bury reactive sites | Switch solvent, add a pseudoproline, use a low-loading resin |
| Multiple cysteines | Orthogonal protecting groups and controlled oxidation needed | Selective deprotection, staged folding, analytical verification |
| Poly-arginine | Steric crowding and premature chain termination | Double coupling, extended coupling times, microwave assistance |
| Beta-sheet repeats | Intermolecular hydrogen bonding causes aggregation | Pseudoprolines, backbone protection, elevated temperature |
| Poly-glycine or poly-alanine | Poor solvation of the resin-bound chain | Modified resin, solvent optimisation |
| N-terminal glutamine | Cyclises to pyroglutamate | Use the pre-formed pyroglutamate derivative if that is the target |
| Adjacent prolines | Slow coupling and incomplete acylation | Extended coupling, double coupling |
Motifs combine. A sequence with a hydrophobic transmembrane stretch, two cysteines and a poly-arginine tail hits three separate problems, and the fixes can conflict with each other. That is when a supplier starts talking about route changes rather than coupling conditions.
Why longer peptides cost disproportionately more
Cost does not scale linearly with length. Reagent consumption rises with every coupling, but the bigger factors are yield loss and purification difficulty. If a 40-mer synthesis yields 40% of the theoretical mass and purification at 95% recovers half of that, you need to start with far more resin than the final quantity implies. The crude product is also more complex, so chromatography takes longer and may need to be repeated.
There is a second effect: the impurities are structurally similar to the product. A truncation missing one residue differs by roughly 100–130 Da, which is a small difference for a large molecule and can translate into a very small retention-time difference. Chemists may need shallower gradients, different column chemistry or orthogonal purification, all of which consume time.
For budgeting, treat anything above 40 residues as a different category from a standard peptide, and anything above 70 as a project that needs a technical discussion before a price is meaningful. The cost drivers article sets out the variables in more detail.
Options when your sequence is long or difficult
Chemistry offers several ways around the length ceiling, and the right choice depends on the sequence and the quantity.
- Fragment condensation: synthesise two or more protected fragments separately, purify them, then join them. Each fragment stays short enough for good coupling efficiency.
- Native chemical ligation: joins an N-terminal cysteine fragment to a thioester fragment, giving a native peptide bond. It is powerful for proteins and long peptides but requires careful design and a cysteine at the junction.
- Recombinant expression: the sequence is produced in bacteria or yeast. This suits long, unmodified chains at larger scale, but adds folding, cleavage and host-cell impurity considerations.
- Stapling and cyclisation: not a workaround for length, but a way to improve stability and conformational definition when a long linear peptide is too flexible for the assay.
- Truncation: the cheapest option when the biology allows it. Map the active region and synthesise a shorter analogue.
For most research projects, truncation or a fragment approach solves the problem at a fraction of the cost of forcing a single long chain. See how peptides are made for the manufacturing comparison.
How to tell in advance whether a sequence will be difficult
Most difficulty can be predicted from the sequence before any reagent is consumed. A quick review covers composition, distribution and local context:
- Count the residues. Above 30, expect additional purification effort; above 50, expect a route discussion.
- Calculate the proportion of hydrophobic residues. A long stretch of Leu, Ile, Val, Phe or Trp is an aggregation signal.
- Count cysteines. Two means a disulfide to form; four or more means regiochemistry and folding work.
- Look for runs of Arg or Lys. Three or more consecutive basic residues slow coupling.
- Check for beta-sheet-prone alternation of hydrophobic and hydrophilic residues.
- Note the N-terminal residue and any sequence that could cyclise, such as Gln to pyroglutamate or Asp to succinimide.
Suppliers run the same checks. A quote that arrives with comments about aggregation risk or an alternative route is a sign the sequence was reviewed, not just priced.
Specification and analytics for long peptides
Long peptides need stronger identity confirmation than a single mass measurement, because a deletion or insertion can produce a mass that is close to the expected value. Ask for MS/MS fragmentation or at least a mass that matches the calculated monoisotopic mass within a tight tolerance, and for the purity to be measured on a gradient that resolves close impurities.
Purity percentages also become harder to interpret as length increases. A 95% area main peak on a 70-mer still leaves a substantial molar fraction of related sequences. For structural or quantitative work, request the impurity profile and discuss whether the specified purity is meaningful for the application.
Finally, confirm how the peptide will be supplied. Long hydrophobic peptides often dissolve poorly, so ask for a solubility note or a small trial sample. The solubility guide describes the screening sequence, and the custom synthesis service can advise on a specific sequence.
Frequently asked questions
What is the maximum length of a synthetic peptide?
Around 120 residues is the practical ceiling for single-chain solid-phase synthesis, and even then only for favourable sequences and specialist laboratories. Routine work sits at 10–40 residues. Longer targets are usually built from fragments or produced recombinantly.
Can you synthesize a peptide with 100 amino acids?
It is possible for a well-behaved sequence, but yield and purity will be low and the cost high. Most suppliers would propose fragment condensation, native chemical ligation or recombinant expression instead. A technical discussion before quoting is essential at that length.
Why do long peptides have lower purity?
Each coupling step leaves a small fraction of unreacted chains. Those truncated sequences accumulate as the chain grows, so the crude product contains a family of closely related impurities that differ by one or a few residues and separate poorly during purification.
What makes a peptide difficult to synthesize?
Hydrophobic stretches that aggregate on resin, multiple cysteines requiring selective oxidation, runs of arginine or lysine, beta-sheet-prone repeats and adjacent prolines are the usual culprits. Combinations of these motifs are harder than the sum of the individual effects.
Can a long peptide be made by recombinant expression instead?
Yes, and it becomes more economical as length and quantity increase. Recombinant routes suit unmodified sequences and can deliver large amounts, but they add folding, cleavage and host-cell impurity considerations, and they are unsuitable for many non-natural modifications.
Does a longer peptide always cost more?
Usually, but the relationship is not linear. Yield loss and purification difficulty mean cost rises faster than length above a certain point. A difficult 25-mer can cost more than a routine 45-mer, so sequence content matters as much as residue count.
Sources and scope
This answer is based on peer-reviewed peptide chemistry and analytical literature, pharmacopoeial requirements (USP <503>, Ph. Eur. 2.2.29 and 2.2.46), FDA and EMA guidance on peptide drug substances, and MOL Changes in-house synthesis and testing data. Product statements describe research-grade peptides supplied for laboratory and manufacturing use. They are not medical advice and are not a substitute for clinical judgement.
